Louis W Sullivan is Director of Emergent BioSolutions Inc.. Currently has a direct ownership of 104,695 shares of EBS, which is worth approximately $868,968. The most recent transaction as insider was on May 23, 2024, when has been sold 17,430 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
0% 3M change
19.97% 12M change
Total Value Held $868,968

LOUIS W SULLIVAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2024
BUY
Grant, award, or other acquisition
-
17,430 Added 14.27%
104,695 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
33,847 Added 27.95%
87,265 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
8,446 Added 13.65%
53,418 Common Stock
May 20 2021
BUY
Grant, award, or other acquisition
-
5,027 Added 10.05%
44,972 Common Stock
May 10 2021
SELL
Payment of exercise price or tax liability
$192,131 $61.62 p/Share
3,118 Reduced 7.24%
39,945 Common Stock
May 10 2021
BUY
Exercise of conversion of derivative security
$192,085 $18.64 p/Share
10,305 Added 19.31%
43,063 Common Stock

Also insider at

UTHR
UNITED THERAPEUTICS Corp Healthcare
LWS

Louis W Sullivan

Director
Silver Spring, MD

Track Institutional and Insider Activities on EBS

Follow Emergent BioSolutions Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS